IMAGE: Dr. Arjun Gupta and Dr. Muhammad Beg said ‘steps taken per day’ are a good indicator of general quality of life among cancer patients. view more
Credit: UT Southwestern
DALLAS – May 1, 2018 – Wearable fitness trackers, such as Fitbits, that measure steps taken per day may be a useful tool to evaluate and help treat cancer patients, researchers at UT Southwestern’s Simmons Cancer Center have shown.
A pilot study of older cancer patients found that they were willing to wear physical activity monitors (PAMs) for 10 weeks or more and used them correctly. Data from the PAMs correlated well with clinician assessment of patient status, the researchers found.
“This is the first step in understanding how relevant wearable devices are for cancer patients. My hope is that we can use wearable devices in large cancer clinical trials. That way, we can see what the true effect of different cancer treatments are on patients’ physical activity,” said senior author Dr. Muhammad Beg, Assistant Professor of Internal Medicine, a Dedman Family Scholar in Clinical Care, and a member of the Harold C. Simmons Comprehensive Cancer Center, one of just 49 National Cancer Institute-designated Comprehensive Cancer Centers in the
Article originally posted at